Prices are updated after-hours


Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date

publishing date : 2021 - 07 - 19    tags : Approval    save search

Almirall receives European Commission approval of Klisyri® (tirbanibulin), an innovative topical treatment for actinic keratosis
Published: 2021-07-19 (Crawled : 21:00) - biospace.com/
ATNX | $0.2031 -7.78% 1.9M twitter stocktwits trandingview |
Health Technology
| | O: -2.26% H: 1.8% C: -0.77%

treatment actinic keratosis europe approval tirbanibulin
Amneal Receives Approval for Generic TobraDex®
Published: 2021-07-19 (Crawled : 21:00) - biospace.com/
AMRX | $5.495 -0.81% 610K twitter stocktwits trandingview |
Health Technology
| | O: -2.09% H: 2.37% C: 2.37%

approval
Athenex Announces European Commission Approval of Klisyri® (tirbanibulin) for the Topical Treatment of Actinic Keratosis
Published: 2021-07-19 (Crawled : 15:00) - globenewswire.com
ATNX | $0.2031 -7.78% 1.9M twitter stocktwits trandingview |
Health Technology
| | O: -2.26% H: 1.8% C: -0.77%

treatment actinic keratosis europe approval tirbanibulin
Ligand’s Partner Merck Receives FDA Approval for VAXNEUVANCE™ for the Prevention of Invasive Pneumococcal Disease in Adults Caused by 15 Serotypes
Published: 2021-07-19 (Crawled : 13:00) - biospace.com/
SNY | $46.19 0.57% 580K twitter stocktwits trandingview |
Health Technology
| | O: -0.68% H: 0.41% C: -0.31%
LGND | $80.23 0.58% 37K twitter stocktwits trandingview |
Health Technology
| | O: -5.38% H: 8.88% C: 8.3%

disease fda fda approval approval pneumococcal
Nicor Gas receives approval for renewable natural gas pilot program
Published: 2021-07-19 (Crawled : 12:00) - prnewswire.com
SO | $67.85 -0.79% 1.2M twitter stocktwits trandingview |
Utilities
| | O: 0.19% H: 1.1% C: -0.22%

renewable natural gas approval program
Nevro Announces FDA Approval of its 10 kHz High Frequency Spinal Cord Stimulation Therapy for Treatment of Chronic Pain Associated with Painful Diabetic Neuropathy (PDN)
Published: 2021-07-19 (Crawled : 12:00) - biospace.com/
NVRO | $12.745 2.04% 56K twitter stocktwits trandingview |
Health Technology
| | O: -3.34% H: 6.11% C: 3.42%

treatment fda fda approval therapy spinal cord approval diabetic chronic pain diabetes
Gainers vs Losers
53% 47%

Top 10 Gainers
WISA 4 | $7.86 349.14% 120M twitter stocktwits trandingview |
Electronic Technology

TPET | $0.4951 114.24% 29M twitter stocktwits trandingview |
n/a

PRSO | $1.99 56.69% 52M twitter stocktwits trandingview |
Manufacturing

PALI | $6.5 56.25% 22M twitter stocktwits trandingview |
Manufacturing

JAGX | $0.1767 48.74% 430M twitter stocktwits trandingview |
Health Technology

SXTC | $2.03 45.0% 27M twitter stocktwits trandingview |
Health Technology

SPCB | $0.3888 40.87% 27M twitter stocktwits trandingview |
Electronic Technology

DYNT | $0.52 40.39% 20M twitter stocktwits trandingview |
Health Technology

SNGX | $0.54 39.86% 7.3M twitter stocktwits trandingview |
Health Technology

BSGM | $1.53 39.09% 2.6M twitter stocktwits trandingview |
Health Technology


Your saved searches
Save your searches and get alerts when important news are released.